AI: More Than a Capability in Pharma

Catch the Full Episode

For the first episode of The End. Talks, Biorce CEO Pedro Coelho sits down with Daniel Lou, who has led pharma services banking at William Blair for over 10 years.

As AI adoption speeds up, Daniel Lou sees it changing clinical development and highly impacting how pharma companies are structured.

In this episode, we discuss:

→ Daniel's path from generalist banking to a decade in pharma services

→ How AI is reshaping critical thinking and the habit of questioning sources

→ Traits that separate successful founders, and how they think about exits

→ How AI is transforming drug discovery through commercialisation

→ Why pharma companies are now becoming more like tech companies

For the first episode of The End. Talks, Biorce CEO Pedro Coelho sits down with Daniel Lou, who has led pharma services banking at William Blair for over 10 years.

As AI adoption speeds up, Daniel Lou sees it changing clinical development and highly impacting how pharma companies are structured.

In this episode, we discuss:

→ Daniel's path from generalist banking to a decade in pharma services

→ How AI is reshaping critical thinking and the habit of questioning sources

→ Traits that separate successful founders, and how they think about exits

→ How AI is transforming drug discovery through commercialisation

→ Why pharma companies are now becoming more like tech companies